蒙大拿 的 肺癌 臨床試驗
14 項針對 肺癌 的研究正在 蒙大拿 各地點尋找參與者。
蒙大拿 的城市
官方研究文本(英文)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- 還有 3 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT04267848Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- 還有 7 項
招募中觀察性研究歡迎健康志工
40 至 75 歲 · 所有性別 · 更新於 2026年10月2日 · NCT05334069Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- 還有 3 項
招募中3 期
70 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT06096844Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- 還有 3 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT04181060Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Saint Vincent Frontier Cancer Center, Billings
- 還有 4 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT06498635Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
- St. Vincent Frontier Cancer Center, Billings
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月29日 · NCT06881784This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- SCL Health - Montana, Billings
- SCL Health - Montana, Billings
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06758401Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- Benefis Sletten Cancer Institute, Great Falls
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年8月17日 · NCT05624996Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- Intermountain Health - St. Vincent Frontier Cancer Center, Billings
招募中1/2 期
18 歲及以上 · 所有性別 · 更新於 2026年6月30日 · NCT06162221Integrated Cancer Repository for Cancer Research
- Bozeman Health Deaconess Hospital, Bozeman
招募中觀察性研究歡迎健康志工
19 至 110 歲 · 所有性別 · 更新於 2026年6月29日 · NCT02012699Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- 還有 3 項
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年6月3日 · NCT05642572Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- 還有 3 項
招募中2 期
18 Minutes · 所有性別 · 更新於 2026年5月5日 · NCT06031688Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- 還有 3 項
招募中2/3 期
18 歲及以上 · 所有性別 · 更新於 2026年5月5日 · NCT06616584SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Billings
招募中觀察性研究
所有年齡 · 所有性別 · 更新於 2025年10月28日 · NCT03452774資料來源:ClinicalTrials.gov,擷取日期 2026年10月5日。各研究自行設定資格標準;由研究團隊決定參與者資格。